Aira Andrea, Arajol Clàudia, Casals-Pascual Climent, González-Suárez Begoña, Martí Silvia, Domínguez M Ángeles, Guardiola Jordi, Soriano Álex
Servicio de Enfermedades Infecciosas, Hospital Clínic de Barcelona, Barcelona, España.
Servicio de Aparato Digestivo. Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Barcelona, España.
Enferm Infecc Microbiol Clin (Engl Ed). 2020 Nov 5. doi: 10.1016/j.eimc.2020.09.002.
Fecal microbiota transplantation (FMT) is an effective and safe treatment to treat recurrent Clostridioides difficile infection. It is essential to make every effort to perform FMT rigorously and based on scientific knowledge. Selection of the fecal microbiota donor is a key point of the process to ensure recipient safety. It is necessary to have protocols of action that allow clinicians to act with the maximum guarantees and to minimize the risks of the procedure. For this reason, a multidisciplinary working group has been set up in Cataluña with the aim of establishing recommendations for the selection of the fecal microbiota donor.
粪便微生物群移植（FMT）是治疗复发性艰难梭菌感染的一种有效且安全的疗法。必须尽一切努力严格且基于科学知识来实施FMT。粪便微生物群供体的选择是确保受体安全这一过程的关键要点。有必要制定行动方案，使临床医生能够在最大保障下开展工作，并将该 procedure 的风险降至最低。因此，加泰罗尼亚成立了一个多学科工作组，旨在制定粪便微生物群供体选择的建议。
